ELP1 and melanoma: For this purpose, C57BL/6 mice were injected subcutaneously with B16 melanoma cells (day −10), and when tumors were palpable (day 0), mice were treated intratumorally with free α-GalCer, fd particles (fdWT), or fd/α-GalCer bacteriophages (Figure 4A).